APA

Bamorovat M., Sharifi I., Fekri A., Keyhani A., Aflatoonian M. R., Heshmatkhah A., Oliaee R. T., Khosravi A., Naderi A., Parizi M. H., Mostafavi M. & Varma R. S. (20190319). A single-group trial of end-stage patients with anthroponotic cutaneous leishmaniasis: Levamisole in combination with Glucantime in field and laboratory models. : Microbial pathogenesis.

Chicago

Bamorovat Mehdi, Sharifi Iraj, Fekri Alireza, Keyhani Alireza, Aflatoonian Mohammad Reza, Heshmatkhah Amireh, Oliaee Razieh Tavakoli, Khosravi Ahmad, Naderi Afsaneh, Parizi Maryam Hakimi, Mostafavi Mahshid and Varma Rajender S. 20190319. A single-group trial of end-stage patients with anthroponotic cutaneous leishmaniasis: Levamisole in combination with Glucantime in field and laboratory models. : Microbial pathogenesis.

Harvard

Bamorovat M., Sharifi I., Fekri A., Keyhani A., Aflatoonian M. R., Heshmatkhah A., Oliaee R. T., Khosravi A., Naderi A., Parizi M. H., Mostafavi M. and Varma R. S. (20190319). A single-group trial of end-stage patients with anthroponotic cutaneous leishmaniasis: Levamisole in combination with Glucantime in field and laboratory models. : Microbial pathogenesis.

MLA

Bamorovat Mehdi, Sharifi Iraj, Fekri Alireza, Keyhani Alireza, Aflatoonian Mohammad Reza, Heshmatkhah Amireh, Oliaee Razieh Tavakoli, Khosravi Ahmad, Naderi Afsaneh, Parizi Maryam Hakimi, Mostafavi Mahshid and Varma Rajender S. A single-group trial of end-stage patients with anthroponotic cutaneous leishmaniasis: Levamisole in combination with Glucantime in field and laboratory models. : Microbial pathogenesis. 20190319.